Literature DB >> 9531795

[Immunohistologic studies of the vitreous humor].

S Dunker1, R Kleinert, J Faulborn.   

Abstract

BACKGROUND: Immunohistological staining of the vitreous is difficult because of its high water content. We present a method for immunohistological staining of celloidin-embedded eyes. Results from diabetic and non-diabetic eyes are demonstrated.
METHOD: Diabetic and non-diabetic eyes were firstly immersed in formol and then slowly dehydrated using rising concentrations of glycerine (sink method). Subsequently, the whole globe was embedded in celloidin and cut into 200-micron sections. Control areas of interest were dissected from the 200 microns sections under a lightmicroscope. These specimens were then embedded in paraffin and cut into 7-micron sections. The 7-micron sections were immunohistochemically stained for type I-collagen, type IV-collagen, fibronectin and laminin.
RESULTS: This method makes immunohistochemical staining of the vitreous possible. Type IV collagen, laminin and fibronection were found at higher concentrations in diabetic eyes than in normal eyes. Type I collagen was detected in neither diabetic nor in normal eyes.
CONCLUSIONS: Our method of examination allows immunohistological staining of the vitreous in its place of origin. Although our method is time consuming, it has some advantages over biochemical analysis: Even minimal changes and their exact distribution can be detected. Our first results show that the vitreous is built up inhomogeneously and that pathological influence can cause structural changes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531795     DOI: 10.1007/s003470050228

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  1 in total

1.  Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.

Authors:  K Probst; R Fijnheer; P Schellekens; A Rothova
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.